Description:
Glycopyrrolate 25 mcg is a long-acting muscarinic antagonist (LAMA) used in the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the muscles around the airways and inhibiting excessive mucus secretion, thereby improving airflow and reducing respiratory symptoms such as coughing, chest tightness, and shortness of breath.
Therapeutic Uses:
Long-term maintenance treatment of COPD
Reduction in the frequency of COPD exacerbations
Improvement of lung function and respiratory comfort
Mechanism of Action:
Glycopyrrolate blocks muscarinic (M3) receptors in the smooth muscles of the airways, preventing bronchoconstriction and helping the airways remain open. Its anticholinergic effect also reduces mucus secretion, contributing to easier breathing.
Dosage Form:
Inhalation (via nebulizer or dry powder inhaler, depending on formulation)
Strength:
25 mcg per actuation/dose
Prescription Status:
Prescription-only medication
Note:
Glycopyrrolate is intended for regular, long-term use and is not suitable for the treatment of acute respiratory symptoms. It should be used under the supervision of a healthcare professional with proper inhalation technique for maximum therapeutic benefit.
Would you like this content tailored for a pharmaceutical catalog or e-commerce product listing?
